Debate: High-risk Pulmonary Embolism – Surgery Is the Way
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Angiodynamics; Penumbra
- Equity/Stock(s)/Options - Viz.ai